Stephen Berenson - May 3, 2023 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
May 3, 2023
Transactions value $
$0
Form type
4
Date filed
5/5/2023, 04:10 PM
Previous filing
May 1, 2023
Next filing
Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +4.6K $0.00 4.6K May 3, 2023 Common Stock 4.6K $130.14 Direct F1
transaction MRNA Restricted Stock Units Award $0 +732 $0.00 732 May 3, 2023 Common Stock 732 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will become fully vested and exercisable on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
F2 The shares subject to this restricted stock unit award will vest in full on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.